Please use this identifier to cite or link to this item: http://hdl.handle.net/10397/91245
PIRA download icon_1.1View/Download Full Text
Title: Peptides for specific inhibition of Jag 1-Notch 1 pathway
Authors: Zhu, X
Chen, Y 
Chan, THW 
Chow, MC 
Issue Date: 14-Sep-2021
Source: US Patent 11,117,932 B2. Washington, DC: US Patent and Trademark Office, 2021.
Abstract: Aberrant cross talk between Notch ligand (e.g. Jag1) and Notch receptor (e.g. Notch1) has been implicated in tumorigenesis in the colon. Inhibition of Notch pathway is therefore an attractive approach for treating diseases with upregulated Jag1 e.g. colorectal cancer (CRC). Pan-notch inhibitors like gamma secretase inhibitors (GSIs) have been developed to inhibit Notch and its downstream events. However, severe gastrointestinal toxicity profiles impede the clinical development of GSIs. The present invention develops novel oligopeptides that specifically inhibit Jag1-Notch1 pathway without interfering DLL1-Notch1 or DLL4-Notch1, which demonstrates a clear advantage over pan-notch inhibitors.
Rights: Assignee: The Hong Kong Polytechnic University
Assignee: The Royal Institution for the Advancement of Learning/McGill University
Appears in Collections:Patent

Files in This Item:
File Description SizeFormat 
us11117932b2.pdf1.84 MBAdobe PDFView/Open
Open Access Information
Status open access
File Version Version of Record
Show full item record

Page views

56
Citations as of Jul 3, 2022

Downloads

1
Citations as of Jul 3, 2022

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.